HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hisakazu Nishimori Selected Research
Hisakazu Nishimori Research Topics
Disease
7
Neoplasms (Cancer)
04/2022 - 05/2005
6
Bronchiolitis Obliterans Syndrome
01/2021 - 01/2012
3
Graft vs Host Disease (Graft-Versus-Host Disease)
04/2022 - 01/2013
3
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2021 - 10/2020
3
Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 05/2009
2
Infections
12/2022 - 06/2021
2
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
07/2022 - 01/2019
2
Wilms Tumor (Wilm's Tumor)
04/2022 - 01/2017
2
Acute Promyelocytic Leukemia
04/2021 - 10/2016
2
Carcinoma (Carcinomatosis)
06/2019 - 05/2005
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2017 - 01/2014
2
Pneumonia (Pneumonitis)
01/2014 - 01/2013
1
Sinusitis
07/2022
1
Measles
06/2022
1
Mumps
06/2022
1
Rubella (German Measles)
06/2022
1
Chickenpox
06/2022
1
Herpes Zoster
06/2022
1
Chorea (Rheumatic Chorea)
10/2021
1
Lymphoma (Lymphomas)
09/2021
1
Sepsis (Septicemia)
06/2021
1
Endometrial Neoplasms (Endometrial Cancer)
04/2021
1
Injection Site Reaction
01/2021
1
Chronic Disease (Chronic Diseases)
01/2021
1
Diarrhea
01/2021
1
Fatigue
01/2021
1
Headache (Headaches)
01/2021
1
Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2021
1
Hemolysis
01/2021
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2021
1
Philadelphia Chromosome
01/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1
Circulating Neoplastic Cells
10/2020
1
Agammaglobulinemia (Hypogammaglobulinemia)
09/2020
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2020
1
Cytopenia
09/2020
1
Primary Myelofibrosis (Myelosclerosis)
08/2020
1
Pulmonary Alveolar Proteinosis
08/2020
1
Lymphadenopathy
06/2019
1
Hematuria
06/2019
1
Progressive Multifocal Leukoencephalopathy
04/2018
1
T-Cell Lymphoma (Lymphoma, T Cell)
12/2017
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2017
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2017
1
Leukemia
01/2017
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017
1
Thrombotic Microangiopathies
04/2016
Drug/Important Bio-Agent (IBA)
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
04/2022 - 04/2009
3
Rituximab (Mabthera)
FDA Link
12/2020 - 04/2009
2
Acids
IBA
03/2021 - 10/2020
2
Hemoglobins (Hemoglobin)
IBA
01/2021 - 06/2012
2
Antigens
IBA
06/2019 - 01/2017
2
Dexamethasone (Maxidex)
FDA Link
Generic
01/2019 - 05/2009
2
Vincristine (Oncovin)
FDA Link
Generic
12/2017 - 04/2009
2
Prednisone (Sone)
FDA Link
Generic
12/2017 - 04/2009
2
Etoposide (VP 16)
FDA Link
Generic
12/2017 - 05/2009
2
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2017 - 04/2009
2
Steroids
IBA
10/2016 - 01/2014
2
tamibarotene
IBA
10/2016 - 01/2012
2
Docetaxel (Taxotere)
FDA Link
10/2010 - 05/2005
2
Cisplatin (Platino)
FDA Link
Generic
10/2010 - 05/2005
1
Messenger RNA (mRNA)
IBA
04/2022
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
09/2021
1
Arsenic Trioxide (Trisenox)
FDA Link
04/2021
1
pegcetacoplan
IBA
01/2021
1
fludarabine
IBA
01/2021
1
eculizumab
FDA Link
01/2021
1
Alkylating Agents
IBA
01/2021
1
Complement System Proteins (Complement)
IBA
01/2021
1
Peptides (Polypeptides)
IBA
01/2021
1
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
10/2020
1
Biomarkers (Surrogate Marker)
IBA
10/2020
1
protoporphyrin IX
IBA
10/2020
1
Immunoglobulin Isotypes
IBA
09/2020
1
Immunoglobulin G (IgG)
IBA
09/2020
1
Proteins (Proteins, Gene)
FDA Link
09/2020
1
ruxolitinib
IBA
08/2020
1
Lipoproteins (Lipoprotein)
IBA
08/2020
1
Surface-Active Agents (Surfactants)
IBA
08/2020
1
Uroplakin III
IBA
06/2019
1
Palmitates
IBA
01/2019
1
HLA Antigens (Human Leukocyte Antigens)
IBA
04/2018
1
Biological Products
IBA
01/2018
1
Anaplastic Lymphoma Kinase
IBA
12/2017
1
Azacitidine (5 Azacytidine)
FDA Link
01/2017
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
10/2016
1
Thrombomodulin
IBA
04/2016
1
Interleukin-12 (IL 12)
IBA
02/2015
1
TOR Serine-Threonine Kinases
IBA
02/2014
Therapy/Procedure
12
Therapeutics
12/2022 - 04/2009
11
Hematopoietic Stem Cell Transplantation
12/2022 - 01/2013
9
Drug Therapy (Chemotherapy)
07/2022 - 05/2005
6
Cell Transplantation
01/2018 - 01/2014
4
Transplantation
01/2021 - 05/2009
2
Photochemotherapy (Photodynamic Therapy)
03/2021 - 10/2020
2
Salvage Therapy
01/2021 - 01/2017
1
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2022
1
Photopheresis
10/2020
1
Haploidentical Transplantation
04/2018
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2014